Recently Published: 100 Questions & Answers About Schizophrenia

DeLisi_QA_Schizophrenia_BigSchizophrenia and its related conditions are all too common among young adults and are prevalent in about 1% of the general population. This is a devastating disorder of thinking; if gone undetected and thus untreated it can lead to robbing an individual of his or her life’s goals and aspirations as it develops. If unchecked, it can lead to either suicidal or violent behavior towards others because the affected individual may become plagued by increasing paranoia, bothersome auditory hallucinations commanding various actions, and a general withdrawal from reality. Lately some unfortunate cases of developing schizophrenia have made the news because of the tragic and deadly events they initiated. These have spurred controversial gun control debates and have brought mental illness to the forefront of these debates about government legislation nationally.

Currently, however, we do have the availability of many medications that if administered early to people developing these symptoms, can lead to recovery and the maintenance of a good quality of life. Doctors and other clinicians who initially see these individuals need to know which of these medications would be helpful and how to use them. There are also many new research findings that examine the brain and genetic make-up of people who develop schizophrenia. These can ultimately lead to new and better treatments and preventive measures.

When a family member has schizophrenia, often a parent does not know whom to turn. 100 Questions and Answers about Schizophrenia, Third Edition provides guidance and understanding about the illness and is a resource for letting family members and individuals suffering from the disease to know where they can go for help and support. It is also a guide for clinicians in the community and other healthcare providers who do not see these patients on an everyday basis and thus may miss the signs and symptoms.

Post written by Lynn E. DeLisi, MD. Dr. DeLisi is the author of 100 Questions & Answers About Schizophrenia and is a professor of psychiatry at New York University and associate director of the Center for Advanced Brain Imaging at The Nathan S. Kline Institute for Psychiatric Research. She is international editor-in-chief of the journal, Schizophrenia Research, and a member of the editorial board of several journals. She has co-authored over 250 scientific publications and has edited or written other scientific books.

Posted in Authors, General Medicine, Patient Education, Pyschiatry & Mental Health | Tagged , , , , , | Comments Off on Recently Published: 100 Questions & Answers About Schizophrenia

Leap Year is Also Rare Disease Day!

MLTPL_WEBx_RD_AppSale_final2

To celebrate this year’s Rare Disease Day, The Tarascon Team is offering a One Day App Sale on all new downloads of our Tarascon Pharmacopoeia mobile app for iPhone, iPad, and Android devices. Enjoy 25% off on Monday, February 29th!

For this year’s Rare Disease Day, we also wanted to highlight a particularly fascinating uncommon condition. Throughout remote towns in Spain and Ecuador, 350 people are diagnosed with Laron’s Disease—a genetic disorder that stops them from growing over four feet tall. Laron’s Syndrome was discovered in 1950 and all 350 people currently diagnosed with Laron’s are descended from a single ancestor with the mutated gene thousands of years ago. Unlike those with dwarfism, people with Laron’s Disease don’t lack a growth hormone, but instead, have mutations in the GHR gene. This gene triggers the growth hormone receptor that binds to the growth hormone. When the receptor binds to the hormone, it triggers the production of the growth-promoting hormone, insulin-like growth factor 1 (IGF-1). So in this case, the cells are unable to trigger the normal growth and function of different tissues.

What makes Laron’s Disease particularly interesting for researchers is that those afflicted with this genetic disorder appear to be resistant to cancer, diabetes, and possibly heart disease and Alzheimer’s. In the future, researchers hope to distill the anti-disease properties into a medicine to fight these illnesses.

Posted in Uncategorized | Comments Off on Leap Year is Also Rare Disease Day!

October 4-10 is Mental Illness Awareness Week! #IAmStigmaFree

The first week of October brings awareness to mental illness and highlights issues, provides support, and works to fight stigma associated with mental health. Did you know, 1 in 17 (14 million) Americans live with a major mental illness like depression, schizophrenia, or bi-polar disorder? According to NAMI (National Awareness on Mental Illness), 1 in 4 (62 million) persons are affected by mental illness, 20% of teens 13-18 have a mental illness, and 18% of adults (42 million) cope with anxiety disorders.

Learn more about mental illnesses with our Question and Answer series including these titles: 100 Questions and Answers About Depression, 100 Questions and Answers About Anxiety, and 100 Questions and Answers About Bipolar Disorder. New edition coming soon: 100 Questions and Answers About Schizophrenia: Painful Minds.

Panic Disorder  Women ADHD  Child OCD  Child Depression  Child ADHD

Posted in Uncategorized | Comments Off on October 4-10 is Mental Illness Awareness Week! #IAmStigmaFree

September is Prostate Cancer Awareness Month!

CaptureProstate cancer is common. In 2012, there were an estimated 2,795, 592 (over 2.5 million) men living with prostate cancer in the United States.  It is estimated that there will be 220,800 new cases of prostate cancer in 2015, accounting for 13.3% of all new cancer cases.  Approximately 27,540 men will die from prostate cancer in 2015. (SEER Stat fact sheets: prostate cancer) It is likely that you know someone, a spouse, significant other, family member or friend with prostate cancer.

The diagnosis is alarming – the choices can be daunting – and feeling overwhelmed is not uncommon.

Trying to navigate one’s way through the evaluation and management of prostate cancer can be akin to walking through a maze and the ongoing advances can add to further confusion.

The evaluation and management of prostate cancer continues to evolve, with a greater understanding of the natural history of prostate cancer, the biology of the cancer cells, refinements in surgical and radiation therapy techniques as well as therapeutic options for recurrent and metastatic prostate cancer.

The adoption of “active surveillance” in select individuals, refinements in surgical procedures, such as robotic assisted laparoscopic radical prostatectomy, and the development of multiple therapies for the management of castrate resistant prostate cancer, prostate cancer cells that continue to grow despite hormone therapy have developed more recently.

Prostate cancer patients, their families, and significant others are faced with difficult treatment choices, often at a time when emotionally they are most impacted.  How do these individuals gather the information they need to make an educated decision or feel “empowered to ask questions”? The internet, although a resource for information, may be difficult to navigate and unfortunately may provide single experiences that don’t reflect the “typical”.  Updating the 100 Questions and Answers: Prostate Cancer attempts to provide current information regarding the diagnosis, evaluation and management of prostate cancer to help prostate cancer patients and their families and significant others feel empowered to ask questions and make treatment decisions.  Knowledge is power – feel empowered to take a more active role in your care or the care of a loved one, spouse or friend.

Post written by Pamela Ellsworth, MD. Pamela Ellsworth is the author of 100 Questions & Answers About Prostate Cancer, 20 Questions & Answers About Metastatic Castration-Resistant Prostate Cancer, 100 Questions & Answers About Men’s Health, among others.

Posted in Uncategorized | Comments Off on September is Prostate Cancer Awareness Month!

Recently Published: 100 Questions & Answers About Ovarian Cancer

Ovarian CancerI am excited and honored to have been given the opportunity to update 100 Questions and Answers About Ovarian Cancer. This edition reflects some important advances in the screening, diagnosis, and treatment of ovarian cancer, as well as a more nuanced approach to topics related to life with or after ovarian cancer.

Books on ovarian cancer are important, because the disease is still so terrifying. Most women and their loved ones fear the worst at the point of diagnosis. However, we have made strides in our understanding of this disease, and this extends to how we approach its management. Today, ovarian cancer can be treated with curative intent. Even for women who relapse, longevity can be measured in many months and into years. This has come about because of researchers, patients, and their advocates- all of whom are committed to improving the lives of women diagnosed, all while aiming to prevent and then cure this cancer.

Important updates include:

  • Introducing the new staging system for ovarian cancer, as published by the International Federation of Gynecology and Obstetrics (FIGO)
  • Novel therapeutics including bevacizumab and olaparib
  • Discussion of promising screening tools, such as the Risk of Ovarian Cancer Algorithm (ROCA)
  • More information on issues focused on quality of life.

We have retained the important and still relevant information previously contributed by my colleague and friend, Nadeem Abu-Rustum, particularly as it relates to the surgical approach to this disease. More importantly, this edition brings in the fresh perspective of Dee Sparacio, who is a tireless advocate for gynecologic cancers as well as an ovarian cancer survivor herself. Along with Dee, we hope the book provides useful information about this disease, and highlights the progress we have made in a field where there is still so much more work to do.

Post written by Don S. Dizon, MD, FACP

Posted in Uncategorized | Comments Off on Recently Published: 100 Questions & Answers About Ovarian Cancer

5-Star Review for Tarascon Primary Care Pocketbook

primary care, physician, resident,  medical student, resource, tarascon, jones & bartlett learning, pocketbookWe are excited to share that our Tarascon Primary Pocketbook has received 5 stars from Doody’s Review Service.

According to Vincent Carr,  DO, MSA, FACC, FACP  (Uniformed Services University of the Health Sciences), writing for Doody’s Review Service,

“This is valuable for every primary care clinician…The pocket-sized format is tremendously important making the book readily available. The chapters are based on a traditional organ-system approach with subchapters focused on specific issues such as acute abdominal pain, abnormal vaginal bleeding, management of back pain, etc. Numerous tables are self-explanatory yet comprehensive.”

Tarascon Primary Pocketbook is a concise yet comprehensive evidence-based overview of the major conditions seen by primary care physicians. Packed with essential lists, and tables, this resource provides instant reminders of hard-to-remember yet vitally important clinical facts. The updated edition includes major updates in over 50 medical conditions, and new chapters in palliative care, oncological emergencies, HIV infection, outpatient pediatric medications, and more.

Would you like to learn more? View the front matter and a sample chapter, or visit the Tarascon website.

Posted in Doody's Review Service, Primary Care | Tagged , , , , , , | Comments Off on 5-Star Review for Tarascon Primary Care Pocketbook

Jones & Bartlett Learning Debuts Digital Review Product for Medical Students Preparing for the USMLE Step 1 and Step 2 CK Exams

usmle, kaplan, uworld, first aid, medical student, med student, medical school, med school, test prep, doctor, physician, NBMEWe’re so proud to announce the debut of USMLE Benchmark, a new digital review product for medical students and residents preparing for the USMLE Step 1 and Step 2 CK exams.

“As leaders in providing high quality medical content and technology, we are pleased to introduce USMLE Benchmark. We spent over a year listening to medical students on their needs to drive better USMLE outcomes. USMLE Benchmark is the result of that effort – an affordable, comprehensive, easy-to-use, one stop destination for medical students,” said Eduardo Moura, Chief Product Officer, Jones & Bartlett Learning.

USMLE Step 1 is designed to assess basic scientific knowledge as it applies to the practice of medicine. USMLE Step 2 CK is intended to assess clinical knowledge and skills as it applies to the diagnosis and management of patients.

Every subscription of USMLE Benchmark includes a 7 block, timed assessment exam that simulates the style of the boards and is based on the most recent NBME blueprint. Also included in each subscription is the ability to create unlimited, custom practice tests in multiple content areas. Users can choose to take practice exams using the actual USMLE interface or USMLE Benchmark’s unique interface.

Each question in USMLE Benchmark includes detailed rationales for both the correct and incorrect answers. All items are written by experienced question writers, medical students, and residents and are meticulously reviewed for clinical accuracy by a medical advisory board consisting of licensed content experts. New questions are always being added and existing questions are regularly analyzed for efficacy.

USMLE Benchmark provides users with custom reports that pinpoint the topics that require more study, individual progress, progress compared to other users, and time spent per question.

For more information, visit our website. Read the entire press release here.

Posted in Jones & Bartlett Learning | Tagged , , , | Comments Off on Jones & Bartlett Learning Debuts Digital Review Product for Medical Students Preparing for the USMLE Step 1 and Step 2 CK Exams

Coming Soon: Tarascon 2015 Pharmacopoeia LARGE PRINT Edition

Large Print PharmacopoeiaEnjoy the mobility of the pocket-sized Tarascon Classic Pharmacopoeia now with larger print size! The newest pocketbook has the same abbreviated content and trim size as the popular Pharmacopoeia series with the convenience of larger, easier to read font. The new Tarascon Pocket Pharmacopoeia 2015 Large Print edition will be available August 8, 2015!

New to the Tarascon Pharmacopoeia 2015 Edition:

• New section dedicated to rheumatology
• FDA guideline updates
• Added tables for quick reference and ease of use
• Removal of discontinued drugs and outdated dosing information

Posted in Uncategorized | Comments Off on Coming Soon: Tarascon 2015 Pharmacopoeia LARGE PRINT Edition

Asking Questions, Getting Answers from Kidney Cancer (Renal Cell Carcinoma) Experts—Helping patients be informed and empowered partners in their care.

CaptureThe National Cancer Institute places kidney cancer among the most common cancers in the United States. The American Cancer Society’s estimates that there will be over 61,000 new cases of kidney cancer each year. Kidney cancer strikes both men and women. The kidneys function as the main filters in the human body, which makes kidney cancer relatively unresponsive to traditional chemotherapy.

The main hope for most kidney cancer patients is that the cancer can be removed surgically. Urologist, Dr. Steven Campbell of the Cleveland Clinic notes, “Kidney cancer has become arguably the most interesting and challenging of all the cancers in modern oncology.” Thanks to tireless work of dedicated researchers and clinicians, surgical and medical advances in the last few years have helped experts like Dr. Campbell to treat kidney cancer patients more effectively and often with less severe side effects.

While the death rate for advanced kidney cancer is still high, there has been an overall gradual decline in recent years. Today, doctors can use anti angiogenic treatments that block the blood vessels supplying tumors with nutrients and oxygen. This therapy can starve a tumor and slow or even reverse its growth. Even advanced tumors that have spread beyond the kidney may respond to immunotherapy and targeted molecular therapy options. Inhibition of checkpoint control is among the recent research advances offering hope to kidney cancer patients. Inhibiting a protein called the programmed death ligand (PDL-1) through pharmacologic manipulation releases a “brake” on the immune system. Many clinical trials of this approach, sometimes combined with other targeted therapies and even new vaccine protocols, are causing excitement in the medical professionals who treat kidney cancer.

These treatments are explained by nationally recognized experts in the Jones and Bartlett Publisher’s 100 Questions and Answers about Kidney Cancer, complete with amazing illustrations provided by the Cleveland Clinic Foundation.

Any diagnosis of cancer is scary—and many patients and their families feel a profound sense of loss of control. This book provides the essential information about kidney cancer that can help patients get “up to speed” with their diagnosis. Written in plain language, with comments by real kidney cancer patients and families, it is designed to inform and empower patients as they consider the best of a variety of treatment options for particular situation.

More information can be found in 100 Questions and Answers About Kidney Cancer, 2nd edition by Steven Campbell, Brian Rini, Robert Uzzo, Brian Lane, and Stephanie Chisolm.

 

Post written by Stephanie Chisolm, co-author of 100 Questions and Answers About Kidney Cancer, 2nd edition. 

 

Posted in Authors | Comments Off on Asking Questions, Getting Answers from Kidney Cancer (Renal Cell Carcinoma) Experts—Helping patients be informed and empowered partners in their care.

The Unhealthiest Meals in American Restaurants

Chain restaurants aren’t known for being the healthiest places to eat, but the Center for Science in the Public Interest (CSPI) recently compiled their annual Xtreme Eating list of the unhealthiest meals in restaurants–meals around 2,000 calories (a day’s worth of food).

Red Lobster’s shrimp version of the “Create Your Own Combination” menu item plus the Traditional Lobsterita tops the CSPI’s list at 3,600 calories. This meal, if you choose the Parrot Isle Jumbo Coconut Shrimp, Walt’s Favorite, Linguine Alfredo, with fries, a Caesar salad and one Cheddar Bay Biscuit, also includes 37 grams of saturated fat and 6,530 mg of sodium.

The Cheesecake Factory, Sonic, and Outback Steakhouse also made the list, check out the full article here: http://www.cspinet.org/nah/xtreme2015.html

Posted in Uncategorized | Comments Off on The Unhealthiest Meals in American Restaurants